Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
AHA 2025 Highlights: New Insights on Icosapent Ethyl
Author(s): Deepak L Bhatt , Payal Kohli Added: 7 months ago
Filmed onsite at the AHA 2025 congress, leading specialists Dr Payal Kohli and Dr Deepak Bhatt explore the evolving landscape of triglyceride-lowering therapy in cardiovascular disease.They review new REDUCE-IT sub-analysis data on icosapent ethyl efficacy by aspirin use, examine updated ESC guideline recommendations and discuss how eicosapentaenoic acid (EPA) delivers cardioprotective benefits… View more

Heart Failure

Prevention & Chronic Conditions
Charles Simonton
Job title: Chief Medical Officer
Personal History Dr. Charles “Chuck” Simonton is based in the San Francisco Bay Area and works at Abiomed as Chief Medical Officer, Vice President of Global Clinical and Medical Affairs. Academic History Dr. Simonton studied at Harvard Medical School between 1976 and 1980 where he earned his MD. He then went on to complete his internship, residency and chief residency in the… View more
Danielle Belardo
Job title: Director of Preventive Cardiology & Co-Director of Research and Education
Personal History Dr Danielle Belardo is a New Yorker who relocated to Philadelphia after college to start her medical career.1 She is now a Preventive Cardiologist based in Newport Beach, California.2 In college, she started volunteering at the Alzheimer’s Association and got involved with the Leukemia & Lymphoma Society’s program to raise funds for the pediatric oncology unit at DuPont… View more
Transthyretin Cardiac Amyloidosis: A Right-atrial Variant
Author(s): Narra Lavanya , Abraham Oomman Added: 1 year ago

Imaging & Diagnostics

Heart Failure
Diagnostic Red Flags are Common in Hypertrophic Cardiomyopathy, Study Finds
Added: 10 months ago Source:  Radcliffe Cardiology
According to European Society of Cardiology (ESC) guidelines, a systematic search for diagnostic clues, or ‘red flags’ (RFs), is recommended in patients with hypertrophic cardiomyopathy (HCM) to help tailor disease management. A new study published in the European Heart Journal has investigated the prevalence and clinical significance of these RFs across different HCM phenotypes and clinical… View more

Imaging & Diagnostics

Inherited and Congenital Cardiac Conditions
Krzysztof Filipiak
Research Area(s) / Expertise:
Specialist in: cardiology, internal medicine, arterial hypertension, clinical pharmacology (4 certified specializations). Education: Medical University of Warsaw (MUW), MD, PhD. Scientific and clinical internships: Medical Faculty, Utrecht University, Netherlands, Medical Faculty, Amsterdam University, Netherlands, Internal Medicine Department, Gaffree e Guinle University, Rio de Janeiro,… View more
José Ramón González Juanatey
Research Area(s) / Expertise:
Personal History Born in Noia and raised in Santiago de Compostela, Dr José Ramón González Juanatey is one of the most renowned cardiologists in Spain.4 Dr Juanatey is Head of the Cardiology and UCC Service of the Santiago de Compostela University Hospital Complex (CHUS) and Professor of Cardiology at the University of Santiago de Compostela (USC).3 Academic History Dr Juanatey… View more
Krzysztof Filipiak headshot
Research Area(s) / Expertise:

Pulmonary Arterial Hypertension

Heart Failure

 Job title: Director-Rector Magnificus, CPME
Specialist in: cardiology, internal medicine, arterial hypertension, clinical pharmacology.Graduated at Medical University of Warsaw (MUW) 1997, MD 2000, PhD 2005, Prof 2007.Scientific and clinical internships: Utrecht, Amsterdam (the Netherlands), Milano, Catania (Italy), Rio de Janeiro (Brasil), Geneve (Switzerland); visiting professor at University of Nis (Serbia), DWU University of Madang … View more
TTR Therapies Show Delayed Mortality Benefit in ATTR-CM
Added: 4 months ago Source:  Radcliffe Cardiology
Therapies for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), including transthyretin (TTR) stabilisers and silencers, have demonstrated a mortality benefit in randomised trials. However, the timing of this benefit has been a subject of debate. A new analysis of three major outcomes trials has evaluated this time course, revealing a consistent pattern across different treatments… View more

Heart Failure
Marcelo F Di Carli
Research Area(s) / Expertise: Job title: Director, CV Imaging
Personal History Dr Marcelo Fernando DiCarli is the Executive Director of Cardiovascular Imaging program and Chief of the Division of Nuclear Medicine and Molecular Imaging, Department of Radiology at Brigham and Women’s Hospital. He is also the Seltzer Family Professor of Radiology and Medicine at Harvard Medical School.2 Academic History He got his M.D. from University of Buenos… View more